Talk to the Institute
Published mark

Sagimet Biosciences Inc.

NASDAQ: SGMT. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0
SEC CIK
0001400118
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
Apr 21, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
David HappelSince Apr 21, 2026
Chair
Not published
Independent
6 / 88 directors published
Published claims
242 distinct sources
Evidence records
70 pinned
Source conflicts
0None open

Built from 2 distinct sources and 7 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Andreas Grauer, M.D. executive of Sagimet Biosciences Inc., effective 2026-04-21.

EffectiveEffective Apr 21, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Medical OfficerAndreas Grauer, M.D.Apr 2026currentSource reportedE3
President, Chief Executive Officer and DirectorDavid HappelApr 2026currentSource reportedE4
Chief Legal and Administrative OfficerElizabeth Rozek, Esq.Apr 2026currentSource reportedE5
Chief Financial OfficerThierry ChaucheApr 2026currentSource reportedE6

Board of directors

Evidence

8 directors published. 6 of 8 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Anne Phillips, M.D.Independent2024None publishedSource reportedE2
Beth Seidenberg, M.D.Independent2007None publishedSource reportedE2
David HappelNot independent2022None publishedSource reportedE2
Elizabeth Rozek, Esq.Independent2021Nominating and Governance, chairNominating and Governance · ChairSource reportedE2
George Kemble, Ph.D.Not independent2015None publishedSource reportedE2
Jennifer JarrettIndependent2024None publishedSource reportedE2
Paul HoelscherIndependent2024Audit, chairAudit · ChairSource reportedE2
Timothy P. WalbertIndependent2024AuditAudit; CompensationCompensationSource reportedE2
Jennifer JarrettIndependence not publishedNot publishedAuditSource reportedE7

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditPaul HoelscherPaul Hoelscher, Jennifer Jarrett, Timothy P. WalbertNot described in the published record
Audit · ChairNot publishedPaul HoelscherNot described in the published record
Audit; CompensationNot publishedTimothy P. WalbertNot described in the published record
CompensationNot publishedTimothy P. WalbertNot described in the published record
Nominating and GovernanceElizabeth Rozek, Esq.Elizabeth Rozek, Esq.Not described in the published record
Nominating and Governance · ChairNot publishedElizabeth Rozek, Esq.Not described in the published record
Committee AppointmentPaul Hoelscher: chair, Audit
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_appointment:18
Committee AppointmentJennifer Jarrett: member, Audit
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_appointment:19
Committee AppointmentTimothy P. Walbert: member, Audit
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_appointment:20
Committee RecordCompensation: Chair not stated; Members Timothy P. Walbert
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_record:21
Committee AppointmentTimothy P. Walbert: member, Compensation
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_appointment:22
Committee RecordNominating and Governance: Chair Elizabeth Rozek, Esq.; Members Elizabeth Rozek, Esq. (Chair)
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_record:23
Committee AppointmentElizabeth Rozek, Esq.: chair, Nominating and Governance
Source reportedE7
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:committee_appointment:24

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerDavid Happel, President, Chief Executive Officer and Director, from Apr 21, 2026
Source reportedE4
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:leadership_role:14
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingSGMT (NASDAQ)
Source reportedE1
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:security_listing:25
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameSagimet Biosciences Inc.
Source reportedE1
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
7 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Sagimet Biosciences Inc. DEF 14A 2026-04-21
    sec proxy. Published Apr 21, 2026. Retrieved Apr 24, 2026. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    SGMT DEF 14A executive officers
    sec filing. Published Apr 21, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    SGMT DEF 14A executive officers
    sec filing. Published Apr 21, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    SGMT DEF 14A executive officers
    sec filing. Published Apr 21, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    SGMT DEF 14A executive officers
    sec filing. Published Apr 21, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    Audit
    board_seats. board seats. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • Andreas Grauer, M.D. executive of Sagimet Biosciences Inc., effective 2026-04-21.
  • David Happel executive of Sagimet Biosciences Inc., effective 2026-04-21.
  • Elizabeth Rozek, Esq. executive of Sagimet Biosciences Inc., effective 2026-04-21.
  • Thierry Chauche executive of Sagimet Biosciences Inc., effective 2026-04-21.
  • Anne Phillips, M.D. seat on Sagimet Biosciences Inc., effective 2024-01-01.
  • Jennifer Jarrett seat on Sagimet Biosciences Inc., effective 2024-01-01.
  • Paul Hoelscher seat on Sagimet Biosciences Inc., effective 2024-01-01.
  • Timothy P. Walbert seat on Sagimet Biosciences Inc., effective 2024-01-01.
  • Audit · Chair committee of Sagimet Biosciences Inc., effective 2024-01-01.
  • Paul Hoelscher member of Audit · Chair, effective 2024-01-01.
  • Audit; Compensation committee of Sagimet Biosciences Inc., effective 2024-01-01.
  • Timothy P. Walbert member of Audit; Compensation, effective 2024-01-01.
  • David Happel seat on Sagimet Biosciences Inc., effective 2022-01-01.
  • Elizabeth Rozek, Esq. seat on Sagimet Biosciences Inc., effective 2021-01-01.
  • Nominating and Governance · Chair committee of Sagimet Biosciences Inc., effective 2021-01-01.
  • Elizabeth Rozek, Esq. member of Nominating and Governance · Chair, effective 2021-01-01.
  • George Kemble, Ph.D. seat on Sagimet Biosciences Inc., effective 2015-01-01.
  • Beth Seidenberg, M.D. seat on Sagimet Biosciences Inc., effective 2007-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/sagimet-biosciences-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership4
  4. Board9
  5. Committees6
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people11
  17. Subject and corrections6
  18. Evidence7
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:9f912be5-4eda-4fcc-86cf-9b7b0f588ce0
  • Cite this recordSagimet Biosciences Inc.
  • Copy canonical URLregistry.alpha.ac/companies/sagimet-biosciences-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Sagimet Biosciences Inc.Company
  • Andreas Grauer, M.D.Person
  • David HappelPerson
  • Elizabeth Rozek, Esq.Person
  • Thierry ChauchePerson
  • Anne Phillips, M.D.Person
  • Beth Seidenberg, M.D.Person
  • George Kemble, Ph.D.Person
  • Jennifer JarrettPerson
  • Paul HoelscherPerson
  • Timothy P. WalbertPerson
  • Jennifer JarrettPerson
  • Sections
    OverviewSagimet Biosciences Inc.
  • MonitoringSagimet Biosciences Inc.
  • LeadershipSagimet Biosciences Inc.
  • BoardSagimet Biosciences Inc.
  • CommitteesSagimet Biosciences Inc.
  • Control and votingSagimet Biosciences Inc.
  • Authority to actSagimet Biosciences Inc.
  • FinancialsSagimet Biosciences Inc.
  • GovernanceSagimet Biosciences Inc.
  • RiskSagimet Biosciences Inc.
  • AI oversightSagimet Biosciences Inc.
  • LegalSagimet Biosciences Inc.
  • CompensationSagimet Biosciences Inc.
  • Other published claimsSagimet Biosciences Inc.
  • Coverage gapsSagimet Biosciences Inc.
  • Linked peopleSagimet Biosciences Inc.
  • Subject and correctionsSagimet Biosciences Inc.
  • EvidenceSagimet Biosciences Inc.
  • Version historySagimet Biosciences Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.